Se encuentra usted aquí

    • You are here:
    • Inicio > CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes

CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes

CRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 DiabetesCRG | IMPaCT T2D Symposium: Genome Sequencing and Precision Medicine for Type 2 Diabetes

ALL_TABS

Program

Day 1
Thursday, 17th November

15.30   IMPaCT, a Spanish Precision Medicine Initiative

Chair: Dídac Mauricio

Welcome

Genomics in the IMPaCT Spanish Personalized Medicine Infrastructure
Mónica Bayes, CNAG

The IMPaCT-T2D Initiative
Silvia Bonàs-Guarch, Center for Genomic Regulation
 

16.30  COFFEE BREAK

17.00  Keynote lectures

Chair: Urko Martínez

Human Genetics in T2D Drug Discovery and Development: A Tale from AstraZeneca’s Genomics Initiative
Slavé Petrovski, Centre for Genomics Research, AstraZeneca

Embracing the complexity of complex disease
Marylyn D. Ritchie, University of Pennsylvania
 

18.00  END OF FIRST DAY

Day 2
Friday, 18th November

9.00    Genomic insights into Mendelian Diabetes

Chair: Luis Castaño

Modeling non-coding genome defects underlying diabetes
Jorge Ferrer, Center for Genomic Regulation

Correctly identifying and treating pathogenic coding variants causing monogenic diabetes
Andrew Hattersley, University of Exeter

10.20  COFFEE BREAK 

10.50  Leveraging complex trait genetics for predictive medicine    

Chair: Arcadi Navarro

The genetic of human height, a model complex trait
Peter Visscher, University of Queensland

Translational genomics of cardiometabolic traits
Eleftheria Zeggini, Helmholtz Zentrum München

From GWAS to function - strategies to gain mechanistic disease insight
Danielle Posthuma, Vrije Universiteit Amsterdam 

12.50  LUNCH 

14.00  Genomics and precision medicine for common forms of diabetes 

Chair: Ana M. Wägner

Type 1 diabetes genetic risk scores for improved classification and prediction of diabetes
Richard Oram, University of Exeter

Towards precision medicine in diabetes: using genetics to understand disease heterogeneity
José Flórez, University of Harvard 

15.20  Closing

15.30  END OF THE SYMPOSIUM